Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
Author(s) -
Vadim V. Klimontov,
Alexander Tsiberkin,
Olga N. Fazullina,
Marina Alekseevna Prudnikova,
Nadezhda Viktorovna Tyan,
В. И. Коненков
Publication year - 2014
Publication title -
diabetes mellitus
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/dm2014175-80
Subject(s) - medicine , hypoglycemia , glimepiride , postprandial , insulin , diabetes mellitus , type 2 diabetes mellitus , metformin , endocrinology , basal (medicine) , continuous glucose monitoring , type 2 diabetes , type 1 diabetes , gastroenterology
Aims. To determine the incidence and risk factors for hypoglycemia in elderly insulin-treated type 2 diabetes mellitus (T2DM) patients by means of continuous glucose monitoring (CGM). Materials and Methods. We observed seventy-six hospitalized patients with T2DM, aged 65 to 79 years. Treatment with basal insulin (n=36), premixed insulin (n=12) or basal-bolus insulin regimen (n=28) was followed by metformin (n=44), glimepiride (n=14) and dipeptidyl peptidase-4 inhibitors (n=14). 2-days CGM with retrospective data analysis was performed in all patients. During CGM, three fasting and three 2-h postprandial finger-prick glucose values were obtained daily with portable glucose meter. Results. Hypoglycemia (identified as blood glucose
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom